Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

Resource type
Journal Article
Title
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial
Abstract
The adjuvanted recombinant zoster vaccine was immunogenic in renal transplant recipients receiving daily immunosuppressive treatment. Humoral and cell-mediated
Publication
Clinical Infectious Diseases
Date
2020/01/02
Volume
70
Issue
2
Pages
181-190
Journal Abbr
Clin Infect Dis
Accessed
1/12/20, 12:20 PM
ISSN
1058-4838
Short Title
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant
Language
en
Library Catalog
Citation
Vink, P., Ramon Torrell, J. M., Sanchez Fructuoso, A., Kim, S.-J., Kim, S., Zaltzman, J., Ortiz, F., Campistol Plana, J. M., Fernandez Rodriguez, A. M., Rebollo Rodrigo, H., Campins Marti, M., Perez, R., González Roncero, F. M., Kumar, D., Chiang, Y.-J., Doucette, K., Pipeleers, L., Agüera Morales, M. L., Rodriguez-Ferrero, M. L., … Oostvogels, L. (2020). Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial. Clinical Infectious Diseases, 70(2), 181–190. https://doi.org/10.1093/cid/ciz177
ORGANISMS
PREVENTION